Reddit Posts
Made some okay investments - Thought someone may be interested?
Trading pharmaceutical stock options around FDA announcements (drug approval/rejection)
FDA to back accelerated approval pathway for gene therapies (NASDAQ:SRPT)
Hot Stocks: XPEV rises on earnings; MARA, MSTR, RIOT boosted by BTC price; FRC, SRPT slide
Hot Stocks: TUP, ANF slump on financial figures; DUOL surges; SRPT climbs on FDA decision
$REV - Hey morons, tired of the fucking trust me bro squeeze ? Check thats's sexy DD !
$REV - Hey morons, tired of the trust me bro squeeze ? Check thats's sexy DD !
Three Biotech Stocks That Could Rise 90% or More, According to Motley Fool
Will AGC see SRPT like rip Monday if they drop merger date in PM?
3 Biotech Stocks That Could Rise 90% or More, According to Wall Street Experts, per Motley Fool
Congrats to all those who stuck with Golden Nugget / Portfolio update
Congrats to all those who stuck with GNOG / Portfolio update
CALLING ALL APES!!!! $SRPT Time to jump in this is going to be big lets make it as big as $GME.
$SRPT this stock is set to squeeze up 26% so far today time to jump in.
Actionable Trading MRNA SRPT CRSP GSK PFE MODERNA HITS $100 Billion GENE RNA MED
Mentions
Ok cool, as inflation climbs the middle class continues to be eaten at and erased. New grads cannot find jobs. The american dream is a literal wall of vapor for young adults wanting to get a foothold in this country. There are many things to cry abt. The markets represent some one of the only ways for people to circumvent these headwinds and give themselves a life once promised to them. Shkreli also called META at its literal picobottom, $99. Did a stream and modeled facebooks fair value live. Hes called SRPT, NBIS, He’s literaly perfectly timed some of his other shorts and given people value. I dont see you doing any of that. Only complain and morally posturing. You can keep posturing tho, its a free country, ill just keep hunting for alpha 👍. Have a good night
$SRPT Sarepta Therapeutics! Come on now!
SRPT - Sarepta Therapeutics. Huge drop due to non-ambulatory deaths but it was a risky population group to begin with, but the company is righting the ship financially and with the FDA so hopefully it'll be on its way back up again
Watching $SRPT closely tomorrow. FDA noise has settled, volume is building, and with expansion on the horizon, September could be the setup month before bigger catalysts hit.
Defo looks good but I guess a death to a ambulatory patient poses a big risk even though very unlikely. Also could you explain to me how rate cuts would be beneficial for SRPT?
Yeah I’ve been eyeing SRPT since Martin Shkreli spoke on them. Only did a few day trades. But yeah seems a good value play.
$SRPT is sitting at $18 in a falling wedge on the 4hr. The selloff came after a patient death scare, but the FDA ruled it wasn’t Elevidys that caused it. The therapy is still working and saving lives — the market just overreacted. Now the stock looks undervalued with bad news already priced in and with that institutions have been buying into the close, which tells me smart money sees upside here. All it may take is a single positive catalyst for SRPT to break above $19–20 and start a bigger reversal.
If you want an honest one, SRPT has solid chances of being a 2-3x bagger, RCKT and EQ are moonshots with 10x potential in a year. Maybe DJT puts? Dogshit fundamentals and it's bound to crash if sentiment shift, or trump dies
I feel that SRPT might really reach $50 this year because I think its fundamentals haven't been significantly affected, so I decided to join the game with the idea of holding until the end of the year. I'm sorry to hear that you want to exit; would you be willing to share why you're exiting so early?
In terms of biotech and pharma in general the space is more risky that normal with all the layoffs and FDA changes. I have been watching SRPT and PFE a lot lately. Both not necesarily small caps but extremely undervalued in my opinion, especially SRPT.
If you're actually looking for moonshots (1% chance to hit 10x is negative EV so idk if you even know what you're asking) check out SRPT More like a 20% chance to 5+ x and a 70% chance to zero out and 10% to chill and make us bored
Imagine being a SRPT bull after today LMFAO
Jokes on 👉u mm’s dropped my SRPT calls to .01 so couldn’t sell 😂
SRPT has doubled in a month while I got shook out by that dumbass with the 0 price target
SRPT dove hard, I bought the dip, and it's rebounded. Gave me a few sheckles right here at the end o the day
It's pharma, look at SRPT and IOVA, they can always dump further.
Big W on those calls 🔥 nearly 100% already and still room to run. If $SRPT momentum keeps up, $60 isn’t as crazy as it sounds. Diamond hands getting rewarded here.
I'm talking the last month, which is when I bought in. Obviously prior to that there has been a lot of bad news, hence the 1 year price chart. The good is the FDA backtracking on their demand for their bread and butter drug to be taken off market, the company announcing a restructuring to increase profitability, most recent earnings significantly beating EPS expectations and positive trial data relating to patient outcomes for their main drug (all recent news, within the past month). The other big thing for me, is normally the stock is hypersensitive to any sort of bad news, again looking at the 1 year chart its pretty clear to see this. Recently a high ranking FDA member, Vinay Prasad, ordered the SRPT drug to be taken off market and was subsequently let go from the FDA (technically resigned), with news reporting this is due to backlash on the trouble he's caused with SRPT. This in itself caused SP to increase. Then a few days, he was reinstated. Normally this kind of news would tank the SP, this time it didnt even dent it. Some are concerned about Prassed having a vendetta against SRPT but I don't think the FDA will want to lose face by flip flopping on their decisions and I think Prassed recent rehiring has probably come after some behind closed doors conversations regarding expectations going forward. To be blunt I think he's been leashed. Seems all the negatives are now priced in and the stock will rise just off the back of no news. Good news should send this sky-rocketing, as its priced at a substantial discount compared to other similarly placed companies. There ya go.
I'm talking the last month, which is when I bought in. Obviously prior to that there has been a lot of bad news, hence the 1 year price chart. The good is the FDA backtracking on their demand for their bread and butter drug to be taken off market, the company announcing a restructuring to increase profitability, most recent earnings significantly beating EPS expectations and positive trial data relating to patient outcomes for their main drug (all recent news, within the past month). The other big thing for me, is normally the stock is hypersensitive to any sort of bad news, again looking at the 1 year chart its pretty clear to see this. Recently a high ranking FDA member, Vinay Prasad, ordered the SRPT drug to be taken off market and was subsequently let go from the FDA (technically resigned), with news reporting this is due to backlash on the trouble he's caused with SRPT. This in itself caused SP to increase. Then a few days, he was reinstated. Normally this kind of news would tank the SP, this time it didnt even dent it. Some are concerned about Prassed having a vendetta against SRPT but I don't think the FDA will want to lose face by flip flopping on their decisions and I think Prassed recent rehiring has probably come after some behind closed doors conversations regarding expectations going forward. To be blunt I think he's been leashed. Seems all the negatives are now priced in and the stock will rise just off the back of no news. Good news should send this sky-rocketing, as its priced at a substantial discount compared to other similarly placed companies. There ya go.
Their partner ARWR has a potential FDA approval in Nov I believe. If that gets approved I'd expect SRPT to pop a bit as well considering SRPT's future depends on the same ARWR technology. Maybe. Idk.
Yall ignoring the SRPT run up big moves are coming I may be an idiot but I’m right on this one! Martin Shrekli boys rise up
Positive FCF, Elevidys is back on the market for ambulatory patients, and the 3rd death wasn’t due to SRPT. They redeemed their shares from ARWR which reduces financial risks even further. They had 850M in cash at the end of June, so I hope they paid some of their debt.
Oh yeah, definitely. People are missing the bigger picture with $SRPT.. The science, clinical data, and unmet need speak for themselves. Even people outside of US are eyeing this gene therapy. So looking at it, this isn’t just a rebound trade.
SRPT is beat to hell and is on the trend up after that fantastic earnings report. Pharmabro endorses it. There's a world where this 5x before the years end.
SRPT up 8% and keeps climbing. Low volume, good news over the weekend
$SRPT Looks like that breakout is happening!
Rolling portfolio into SRPT, finally catching attention
If youre not all in SRPT then you aint black
SRPT is shooting up on no volume, big news coming
I know theres atleast a handful of us making a killing on SRPT right now. Shoutout whoever posted the DD on it a week or so ago. So much more room to run. LFG boys
QUBT had a train wreck of an earnings call with 60k revenue, yet has a higher market cap than SRPT with over 600 million in quarterly revenue
SRPT and Piedmontt Lithium calls for some multi baggers
I bought SNDX at 9.20 and anticipate it going to 28-30. I bought TARS at $40, hanging tight. Recently buying the heck out of VKTX and SRPT. Got 5,000 shares of SRPT below $18 and honestly think it’s going back to $80. Bought ETHA Dec calls in June. Up 540% and absolutely not selling. Bought LQDA at $19 in anticipation of earnings Monday. Rocking now. HROW been an absolute winner. I have others that I’m not selling. Building a position in IDYA. Supposed to release data today but it got embargoed. I think it’s gonna be exceptional, and is being delayed to Sept
Yes I got 100 shares of SRPT 🚀
SRPT still not too late to buy for the spike
SRPT is a easy 2x next few months gap fill incoming
POET shares, SRPT calls, and MNDY calls. I'm ready to be a millionaire.
SRPT and RKT seem to be popping off
SRPT is doing what UNH bagholders were hoping for
Shoutout all my dawgs that bought SRPT two weeks ago
SRPT looking for that breakout! Amazing opportunity for a company that got beat down very temporarily because of FDA bs, which only lasted a week. They bringing billions and revenue and crushed the latest earnings report! Went from 150 down to almost 10, on its way back up!
$SRPT Analysts offer an average one-year price target of $30.28, indicating a 74.22% upside. GuruFocus estimates a potential 1147.47% upside with a projected GF Value of $216.81. I like Guru Focus thoughts here $216.81! Ha 💪 https://www.gurufocus.com/news/3013010/sarepta-therapeutics-srpt-upgraded-as-fda-clears-elevidys-concerns
Surely it's SRPT if anyone isn't buying they're dumb and that's probably what his announcement will be.
SRPT soon will launch. Feeling says a buyout but shorts may cover before then
$SRPT was $150 a year ago, they just crushed expectations, drugs, back on the market and pretty sure the FDA will clear whatever comes in as long as it’s reasonable. So many catalyst could send this north though really fast, especially with the ridiculously high short interest. All price targets by 30 or so analysts are higher. And then there’s always a possibility of an acquisition since it’s beaten down artificially so low. Lots going for it here, always risk when it comes to biotech, but this situation looks pretty sweet.
Stocks I like (especially for August 14th): $RR, $PSTV, $SRPT, $BLSH (new crypto IPO lists on the 13th!), and$PEW
At $17 pe share that is priced in (sales of PMO only, excluding Elevidys) the point is it is extremely difficult to withdraw drugs like Elevidys from the market, I think based on the current data it is very unlikely and because of this, SRPT seems incredibly cheap. Once the dust settle, I think a big pharma will acquire them for $60-80
Retards who bought SRPT are now bagholders for life.
he is probably not allowed to touch SRPT again, but investors will be fucking scared
I like SRPT and have a position in it. I think it's unfairly kept down, it may go up but it's probably going to be choppy. I don't know about ABCL, didn't do any research on that one. IMO short term potential VKTX >>> SRPT, SRPT doesn't really have short term catalysts coming.
As a bio quant, would you say VKTX is a better buy than ABCL or SRPT?
NVO and SRPT , I sold my whole portfolio and put it into these at there bottoms hopefully
$SRPT seems like value play. Pretty risky though
If Shrekhli is correct how come there hasn’t been any inside buying since May when the stock price was in the 30s.SRPT is in high teens and the insider’s aren’t even buying not sure what to think https://preview.redd.it/p86p2xcotzhf1.jpeg?width=1125&format=pjpg&auto=webp&s=00ce94960d6422c2b700ceff41cc30ec8330c130
SRPT - tons of posts about it already, not another stupid mementoes likely to pump and dump. Very easy to see why it dropped and why it will go back up (just look at the other reddit posts about it I cbf summing it up). Actually has a proven, good product already established, selling and making money. Beat expectations in recent earnings etc etc. This one is my go to for the safest minimum 2x in short term. Playing it while I take a break from the pump and dumps.
SRPT - Sarepta Therapeutics. They got beaten down from their high of around $160 but has since been derisked (mostly) from the FDA drama. This company pulls in over $2 billion in revenue with a gene therapy drug that's the only one in this class for Duchenne muscular dystrophy. I'm looking for $50 at least by EOY if not sooner.
I got a very similar position in SRPT too, 2420 shares, here's hoping everything works out :)
undervalued leader. De Shaw just bought 5 million shares. The stock is up 8% after earnings. The craziest thing about SRPT is that retail doesn’t even know it exists. The tech is clean. The kids are walking. And the market hasn’t priced in a single international expansion yet.
Lol. Open is trash that was a straight pump and dump Sarepta Therapeutics, Inc. SRPT reported second-quarter 2025 adjusted EPS of $2.02, which beat the Zacks Consensus Estimate of $1.11. This beat was mainly due to higher-than-expected collaboration revenues coupled with lower operating expenses incurred during the quarter. In the year-ago period, the company posted an adjusted EPS of 43 cents. The adjusted figures exclude depreciation and amortization costs, stock-based compensation expenses and gains on strategic investments. Including these items, EPS during the quarter was $1.89, compared to 7 cents in the year-ago period. Sarepta recorded total revenues of $611.1 million, up 68% year over year. The upside was driven by sales of Elevidys, its one-shot gene therapy for Duchenne muscular dystrophy
$26 calls on SRPT 8/15. I’ve had worse ideas.
That guy with SRPT $20 calls about to win.
SRPT and Piedmontt Lithium are both so freakin solid right now LFG
SRPT is the move, institutions are loading in, this is going to fly
I got $200k in SNDX. Bought low 9s. They are executing very well. One of their drugs is collab with INCY, and they just had a board member (Bill Meury) resign in June and joined as INCY new CEO. I think INCY may buy them out. Looking at $24-30 range. Meury has a history of acquisitions so this is my bet. Heavy options activity on LQDA. They got through some litigation and are finally able to sell their drug. Inhaled drugs are super hot now (look up VRNA ). Earnings coming out 12th. I’m not the biggest ER player but if they have good sales, it’s gonna explode higher. CRNX is a quiet play, waiting for drug approval in Sept. they have an oral drug for Acromegaly. “Should” be approved because study was double blind. After that they’ll ramp up sales and should do well. With biotech usually you wanna see if the first quarter after launch is good and see traction. Massive risk-reward plays: SRPT and VKNG. Both have +400% potential
SRPT saw one post about it
Sarepta Therapeutics (SRPT) - dragged down on negative news that has more or less been de-risked, and it's not unthinkable for this to bounce above $80 by EOY
Once the shorts get flushed out $SRPT will rocket 🚀 Bought 1k shares!
SRPT huge short float jeffries upgrade today to 50
SRPT huge short float jeffries upgrade today to 50